ScholarIQanswers from OpenAlex & ORCID
Sijin Wen
ResearcherPublications, citations & collaboration network
Sijin Wen is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Sijin Wen have?
ScholarIQindexed works
Sijin Wen has 531 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Sijin Wen have?
ScholarIQcitation count
Sijin Wen has 15,336 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Sijin Wen?
ScholarIQh-index
Sijin Wen has an h-index of 64 in OpenAlex.
What is the i10-index of Sijin Wen?
ScholarIQi10-index
Sijin Wen has an i10-index of 189 in OpenAlex.
What is the ORCID of Sijin Wen?
ScholarIQorcid
The ORCID for Sijin Wen is on the source record.
What is the OpenAlex record for Sijin Wen?
ScholarIQopenalex
The OpenAlex for Sijin Wen is on the source record.
What are the most-cited papers on Sijin Wen?
ScholarIQmost cited works
Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia
Constantine S. Tam, Susan O’Brien, William G. Wierda, Hagop M. Kantarjian, Sijin Wen, Kim‐Anh Do, Deborah A. Thomas, Jörge E. Cortes, Susan Lerner, Michael J. Keating
Personalized Medicine in a Phase I Clinical Trials Program: The MD Anderson Cancer Center Initiative
Apostolia M. Tsimberidou, Nancy G. Iskander, David S. Hong, Jennifer J. Wheler, Gerald S. Falchook, Siqing Fu, Sarina A. Piha‐Paul, Aung Naing, Filip Jankú, Rajyalakshmi Luthra, Ye Yang, Sijin Wen, Donald A. Berry, Razelle Kurzrock
Chemoimmunotherapy With Fludarabine, Cyclophosphamide, and Rituximab for Relapsed and Refractory Chronic Lymphocytic Leukemia
William G. Wierda, Susan O’Brien, Sijin Wen, Stefan Faderl, Guillermo Garcia‐Manero, Deborah A. Thomas, Kim‐Anh Do, Jörge E. Cortes, Charles Koller, Miloslav Beran, Alessandra Ferrajoli, Francis J. Giles, Susan Lerner, Maher Albitar, Hagop M. Kantarjian, Michael J. Keating
CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma
Padmanee Sharma, Yu Shen, Sijin Wen, Sachiko Yamada, Achim A. Jungbluth, Sacha Gnjatic, Dean F. Bajorin, Victor E. Reuter, Harry W. Herr, Lloyd J. Old, Eiichi Sato
Phase II Trial of Infusional Fluorouracil, Irinotecan, and Bevacizumab for Metastatic Colorectal Cancer: Efficacy and Circulating Angiogenic Biomarkers Associated With Therapeutic Resistance
Scott Kopetz, Paulo M. Hoff, Jeffrey S. Morris, Robert A. Wolff, Cathy Eng, Katrina Y. Glover, R. Adinin, Michael J. Overman, V VALERO, Sijin Wen, Christopher H. Lieu, Shaoyu Yan, Hai T. Tran, Lee M. Ellis, James L. Abbruzzese, John V. Heymach